This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: The Innovations of Tadashi Kadowaki
Introduction
Tadashi Kadowaki is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 3 patents, Kadowaki's work focuses on biomarkers that enhance the effectiveness of therapies for various types of cancer.
Latest Patents
Kadowaki's latest patents include groundbreaking discoveries in the realm of cancer treatment. One of his notable patents is related to biomarkers for predicting and assessing the responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds. These biomarkers are crucial for determining a patient's responsiveness to therapies involving lenvatinib or its pharmaceutically acceptable salts, such as lenvatinib mesylate. This innovation is instrumental in selecting appropriate treatment modalities for patients diagnosed with or at risk of developing thyroid or kidney cancer.
Another significant patent by Kadowaki focuses on biomarkers for predicting and assessing the responsiveness of endometrial cancer subjects to lenvatinib compounds. This invention provides valuable insights into whether a patient with endometrial cancer will respond to lenvatinib therapy. The biomarkers, compositions, and methods described in this patent are essential for tailoring treatment strategies for patients with endometrial cancer.
Career Highlights
Kadowaki is currently associated with Eisai R&D Management Co., Ltd., where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve patient outcomes through personalized medicine.
Collaborations
Throughout his career, Kadowaki has collaborated with esteemed colleagues, including Yasuhiro Funahashi and Junji Matsui. These collaborations have further enriched his research and contributed to the development of innovative cancer treatments.
Conclusion
Tadashi Kadowaki's contributions to cancer research through his patents and collaborations highlight his commitment to improving patient care. His work in identifying biomarkers for cancer treatment represents a significant advancement in the field of oncology.